Ingredients / Retinol

Retinol

A vitamin A derivative widely studied for photoaging, fine lines, and acne. One of the most evidence-backed topical ingredients.

Understanding evidence levels▼
In VitroCell or tissue culture experiments — no human or animal data.
Ex VivoSkin model or tissue experiments — not in living humans.
Animal StudyResults in animals only — may or may not translate to humans.
Small Human StudySmall or uncontrolled human study — preliminary results.
Controlled TrialControlled human study (often randomized) — stronger evidence.
Systematic ReviewSummary and analysis of existing published studies.
Meta-AnalysisStatistical pooling of results from multiple studies.
GuidelineProfessional guidance or consensus statement from a dermatology society.

Research findings(1309)

◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.AcnePublished: August 13, 2026

Benzoyl peroxide's effectiveness and safety in dermatology

Benzoyl peroxide, a common acne treatment, was studied for its effectiveness and safety in treating various skin conditions. Researchers found that it can reduce lesions and improve symptoms in some cases, but also cause skin irritation. The long-term safety of benzoyl peroxide is still being evaluated.

Why it matters: Understanding benzoyl peroxide's effects can help dermatologists and patients make informed decisions about its use.

The study's findings are based on a systematic review of existing research, which may have included small or biased studies. Further research is needed to confirm the results and establish benzoyl peroxide's efficacy in other dermatological conditions.

PubMed↗
In VitroCell or tissue culture experiments. No human or animal data.AcnePublished: August 12, 2026

Dual drug-loaded microneedles may help treat acne

Researchers developed a new type of microneedle that can deliver two different acne-fighting drugs through the skin. In lab experiments, this combination showed promise in reducing acne-causing bacteria and oil production. The microneedles were found to be safe and effective in a controlled environment.

Why it matters: This study may contribute to the development of more effective treatments for acne, a common skin condition affecting many people.

This study was conducted in a lab and involved only in-vitro experiments, so its findings may not directly translate to human skin. Further research is needed to confirm these results in a real-world setting.

PubMed↗
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.AcnePublished: July 7, 2026

High-Dose Retinoid Use May Not Increase Mortality Risk

Researchers studied the use of high-dose topical and oral isotretinoin in acne patients and found no increased risk of death. This was a large study that matched patients with and without retinoid exposure. The results suggest that retinoids may be safe for use in dermatology, but more research is needed.

Why it matters: This study may provide reassurance for clinicians prescribing retinoids for acne and other skin conditions.

This study was a retrospective cohort study, which means it looked back at existing data. The results may not apply to all patients or situations.

PubMed↗
Small Human StudySmall or uncontrolled human study. Results are preliminary.AcnePublished: July 6, 2026

New Approaches to Treating Acne May Help Improve Outcomes

Researchers studied acne vulgaris, a common skin condition, and its treatment options. They looked at conventional and herbal therapies, as well as new delivery systems using nanotechnology. The study found that some plant extracts and nanocarriers may help reduce acne symptoms, but more research is needed to confirm these findings.

Why it matters: Understanding new approaches to treating acne may lead to improved treatment options for people affected by this common skin condition.

The study's findings are based on a review of existing research and may not reflect the results of a single, large-scale study. The effectiveness of these new approaches has not been extensively tested in humans.

PubMed↗
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.AcnePublished: July 3, 2026

Researchers studied essential oil-loaded nanocarriers for acne treatment

Scientists looked at how essential oils can be delivered in tiny particles to help with acne. They used computer models and lab experiments to design the best way to deliver these oils. The goal is to create a more effective and safer treatment for acne.

Why it matters: This research may lead to new, more effective treatments for acne that are also safer and more personalized.

The study is a review of existing research, not a new experiment. It's unclear what specific essential oils or nanocarriers were studied, and more research is needed to confirm these findings.

PubMed↗
Small Human StudySmall or uncontrolled human study. Results are preliminary.Dry SkinPublished: June 24, 2026

SDR9C7 Gene Variants Linked to Rare Skin Conditions

A small study looked at eight people with a rare skin condition caused by SDR9C7 gene variants. Researchers found that these individuals often had fine scaling, dry skin, and skin infections. They also found that some treatments, like topical emollients and hydrocortisone, may help improve symptoms.

Why it matters: Understanding the effects of SDR9C7 gene variants on skin health may help researchers develop more effective treatments for this rare condition.

This study had a small sample size and focused on a specific group of people with a rare condition, so its findings may not be generalizable to others.

PubMed↗
Animal StudyResults in animals only. May or may not translate to humans.Skin Barrier DamagePublished: June 10, 2026

DGAT1's role in skin cell growth studied

Researchers studied how a protein called DGAT1 affects skin cell growth. They found that without DGAT1, skin cells grow too quickly and the skin barrier is disrupted. However, in conditions like psoriasis, DGAT1 seems to have the opposite effect, slowing down skin cell growth.

Why it matters: Understanding how DGAT1 affects skin cell growth may help us better understand skin conditions like psoriasis.

This study was conducted in mice and in lab experiments, so its findings may not directly apply to humans. Further research is needed to confirm these results.

PubMed↗
Small Human StudySmall or uncontrolled human study. Results are preliminary.Redness / Facial RednessPublished: June 7, 2026

Apremilast May Help Treat Rare Skin Condition

Researchers studied apremilast, a medication, for treating a rare skin condition called acrodermatitis continua of Hallopeau. They found that in a small group of patients, apremilast may help reduce skin symptoms and joint pain. However, more research is needed to confirm these findings.

Why it matters: This study may help doctors find new treatment options for patients with this rare skin condition.

This study included only two cases and eight cases from literature, and the results may be influenced by publication bias. The study also found that one patient did not respond well to apremilast.

PubMed↗
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.AcnePublished: June 3, 2026

New Strategies for Reducing Acne-Induced Hyperpigmentation

Researchers studied acne-induced hyperpigmentation, a common side effect of acne, and found that it can persist for months or years. They identified risk factors and treatment options, including topical agents and systemic therapies. More research is needed to develop standardized assessment tools.

Why it matters: Understanding and managing acne-induced hyperpigmentation may help improve the quality of life for individuals affected by acne.

This study did not address the effectiveness of all potential treatments, and more research is needed to develop standardized assessment tools for acne-induced hyperpigmentation.

PubMed↗
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.AcnePublished: June 1, 2026

New Acne Treatment May Help Reduce Inflammation and Improve Skin Appearance

A small study of 40 patients with moderate-to-severe acne found that a topical treatment combining retinol and site-specific salicylic acid may help reduce inflammation and improve skin appearance. The treatment was applied for 12 weeks and showed significant improvements in acne severity and post-inflammatory hyperpigmentation. However, more research is needed to confirm these findings.

Why it matters: This study may contribute to the development of more effective acne treatments and improve our understanding of how to manage skin inflammation and appearance.

This study had a small sample size and a short duration of 12 weeks.

PubMed↗
Small Human StudySmall or uncontrolled human study. Results are preliminary.WrinklesPublished: June 1, 2026

Retinol-Laden Liposomes May Improve Skin Penetration

Researchers developed deformable liposomes to deliver retinol, an anti-wrinkle agent, more efficiently through the skin. They tested five different formulations and found that one of them, ML-4, allowed for a 10.6% increase in retinol penetration compared to a conventional liposome. This suggests that ML-4 may be a useful delivery system for functional cosmetic materials.

Why it matters: This study may help improve the effectiveness of anti-aging skincare products by enhancing their ability to penetrate the skin.

This study was conducted in a lab setting using a small number of human subjects and tested the delivery of retinol, a common ingredient in anti-aging skincare products.

PubMed↗
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Published: May 28, 2026

L-ascorbic acid 15% serum compared to retinol 0.1% for skin aging

A small study compared the effectiveness and safety of L-ascorbic acid 15% serum to retinol 0.1% serum for treating skin aging. Researchers found both treatments improved skin appearance, but no significant differences were observed between the two. The study suggests L-ascorbic acid may be as effective and safe as retinol for anti-aging therapy.

Why it matters: This study may help inform skincare choices for individuals looking to address skin aging.

This was a small, double-blind, randomized controlled trial with assessments conducted on participants' cheeks at weeks 2 and 4.

PubMed↗